The Lancet Commission on Investing in Health

The Lancet Commission on Investing in Health (CIH), chaired by former U.S. treasury secretary Lawrence Summers, and co-chaired by health economist Dean Jamison, brings together an international group of 50 expert commissioners from a wide range of disciplines—including public health, health economics and financing, demography, and clinical medicine—to examine the benefits of investing in health. The first CIH report (CIH 1.0), “Global Health 2035: A World Converging in a Generation,” published in 2013, provided a roadmap to achieving a “grand convergence” by 2035—a universal reduction in maternal and child deaths and deaths from infectious disease down to levels seen in the best-performing middle-income countries. Its second report (CIH 2.0), “Alma Ata at 40 years,” published in 2018 to mark the 40th anniversary of the Alma Ata Declaration, assessed progress towards grand convergence and reflected on the future of the global push for universal health coverage. On October 15, 2024, the CIH will launch its third report (CIH 3.0) at the World Health Summit in Berlin. The third report, “Global Health 2050: The Path to Halving Premature Death By Mid-Century,” identifies opportunities for a “reset” in global health.